Form Type: 4

SEC EDGAR Link
Accession Number:0001127602-22-013206
Date:2022-05-02
Issuer: HAEMONETICS CORP (HAE)
Original Submission Date:

Reporting Person:

DARECCA JAMES
125 SUMMER STREET
BOSTON, MA 02110

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-05-02 A 5,902 a $0.00 5,902 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 50.83 2022-05-02 deemed execution date A 13,828 (a) 2029-05-02 common stock 13,828 $50.83 13,828 direct
Footnotes
IDfootnote
f1 the securities awarded are in the form of restricted stock units ("rsus") issued pursuant to the haemonetics corporation 2019 long-term incentive compensation plan. the rsus vest in annual increments of 25% beginning on the first anniversary of the date of grant.
f2 each rsu represents a contingent right to receive one (1) share of the issuer's common stock when vested.
f3 option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
WhaleWisdom Logo

Elevate your investments